Cell adhesion molecules, simvastatin and hormone replacement therapy, in coronary artery disease

successful revascularization. J Am Coll Cardiol 1998; 31: 1040–8. [10] Di Carli MF, Asgarzadie F, Schelbert HR et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995; 92: 3436–44. [11] Haas F, Haehnel CJ, Picker W et al. Preoperative positron emission tomographic viability assessment and preoperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997; 30: 1693–700. [12] Bax JJ, Wijns W. FDG imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging? J Nucl Med 1999; 40: 1893–5. [13] Previtali M, Lanzarini L, Poli A, Fetiveau R, Barberis P. Dobutamine stress echocardiography early after myocardial infarction treated with thrombolysis. Int J Card Imaging 1996; 12: 97–104. [14] Bax JJ, Van Eck-Smit BFL, Van der Wall EE. Assessment of tissue viability: clinical demand and problems. Eur Heart J 1998; 19: 847–58. [15] Iskander S, Iskandrian AE. Prognostic utility of myocardial viability assessment. Am J Cardiol 1999; 83: 696–702.